![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Taro Pharmaceutical Industries, Ltd. Haifa Bay Il, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Mometasone furoate, Micronised, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2010-349 - Rev 03
This Chemical Type CEP, issued on October 12, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1449 associated with this CEP further emphasizes